Jilin Province Great Great Pharmaceutical Co. LTD

Jilin Province Broadwell Pharmaceutical Co., LTD. Welcome you!

Service hotline:+86-431-85639055

博大伟业
imgboxbg

NEWS CENTER

Your current location:
Homepage
/
/
/
Seminar on polycenter clinical research protocols for Polyprion Zinc

Seminar on polycenter clinical research protocols for Polyprion Zinc

  • Categories:The news
  • Author:
  • Origin:
  • Time of issue:2020-08-08
  • Views:0

(Summary description)    Solstice on July 6, 2013, 7, by the great feats of jilin province pharmaceutical co., LTD., bid, Peking union medical college hospital as the leader of the unit, Shanghai yan chai hospital, jiangsu province people's hospital, zhongshan hospital in xiamen, the first hospital of jilin university, the first affiliated hospital of nanchang university, shandong qilu hospital, xiangya hospital, medical school first affiliated hospital of zhejiang university for the unit of "triple therapy in combination with poly pury zinc (3 + P therapy) in the treatment of helicobacter pylori correlation gastritis multicenter, randomized, parallel controlled clinical studies" Marco Polo scheme seminar in Beijing hotel is held ceremoniously. A total of 17 people from 11 centers attended the workshop.

    The "triple therapy in combination with poly pury zinc (3 + P therapy) in the treatment of helicobacter pylori correlation gastritis multicenter, randomized, parallel controlled clinical studies" preliminary finalized test scheme are discussed, in order to further improve the test scheme, the content of the informed consent form, confirm the group, the exclusion criteria and check project, definite curative effect evaluation standard, and let each expert and the teacher knows the whole test process. In order to make the program of "a multicentric, randomized, parallel controlled clinical study on the treatment of Helicobacter pylori associated gastritis with triple therapy combined with polyprazole (3+P therapy)" more rigorous, scientific and ethical requirements.

Seminar on polycenter clinical research protocols for Polyprion Zinc

(Summary description)    Solstice on July 6, 2013, 7, by the great feats of jilin province pharmaceutical co., LTD., bid, Peking union medical college hospital as the leader of the unit, Shanghai yan chai hospital, jiangsu province people's hospital, zhongshan hospital in xiamen, the first hospital of jilin university, the first affiliated hospital of nanchang university, shandong qilu hospital, xiangya hospital, medical school first affiliated hospital of zhejiang university for the unit of "triple therapy in combination with poly pury zinc (3 + P therapy) in the treatment of helicobacter pylori correlation gastritis multicenter, randomized, parallel controlled clinical studies" Marco Polo scheme seminar in Beijing hotel is held ceremoniously. A total of 17 people from 11 centers attended the workshop.

    The "triple therapy in combination with poly pury zinc (3 + P therapy) in the treatment of helicobacter pylori correlation gastritis multicenter, randomized, parallel controlled clinical studies" preliminary finalized test scheme are discussed, in order to further improve the test scheme, the content of the informed consent form, confirm the group, the exclusion criteria and check project, definite curative effect evaluation standard, and let each expert and the teacher knows the whole test process. In order to make the program of "a multicentric, randomized, parallel controlled clinical study on the treatment of Helicobacter pylori associated gastritis with triple therapy combined with polyprazole (3+P therapy)" more rigorous, scientific and ethical requirements.

  • Categories:The news
  • Author:
  • Origin:
  • Time of issue:2020-08-08
  • Views:0
Information

    Solstice on July 6, 2013, 7, by the great feats of jilin province pharmaceutical co., LTD., bid, Peking union medical college hospital as the leader of the unit, Shanghai yan chai hospital, jiangsu province people's hospital, zhongshan hospital in xiamen, the first hospital of jilin university, the first affiliated hospital of nanchang university, shandong qilu hospital, xiangya hospital, medical school first affiliated hospital of zhejiang university for the unit of "triple therapy in combination with poly pury zinc (3 + P therapy) in the treatment of helicobacter pylori correlation gastritis multicenter, randomized, parallel controlled clinical studies" Marco Polo scheme seminar in Beijing hotel is held ceremoniously. A total of 17 people from 11 centers attended the workshop.

    The "triple therapy in combination with poly pury zinc (3 + P therapy) in the treatment of helicobacter pylori correlation gastritis multicenter, randomized, parallel controlled clinical studies" preliminary finalized test scheme are discussed, in order to further improve the test scheme, the content of the informed consent form, confirm the group, the exclusion criteria and check project, definite curative effect evaluation standard, and let each expert and the teacher knows the whole test process. In order to make the program of "a multicentric, randomized, parallel controlled clinical study on the treatment of Helicobacter pylori associated gastritis with triple therapy combined with polyprazole (3+P therapy)" more rigorous, scientific and ethical requirements.

Scan the QR code to read on your phone

Jilin Province Great Great Pharmaceutical Co. LTD

Service hotline

+86-431-81158731

CONTACT US

Jilin Province Great Great Pharmaceutical Co. LTD

Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD

Liaoyuan Production Base: No. 158 Fortune Road, Liaoyuan Economic Development Zone, Jilin Province

Tel:+86-437-6998023

Changchun R&D Center: No. 3786 Juye Street, Jingyue Development Zone, Changchun City, Jilin Province
Tel:+86-431-81158731(Marketing center)

Tel:+86-431-81158756(Research and development center)

Beijing Office: Room 901, Building F, Kaixuan City, 170 Beiyuan Road, Chaoyang District, Beijing
Tel:+86-10-58236233

Medication consultation, feedback on medication adverse reaction, and user complaint telephone:0437-5029815 

NO PUBLIC

Jilin Province Great Great Pharmaceutical Co. LTD

Scan and follow the official official account

Copyright © Jilin Province Great Great Pharmaceutical Co. LTD        吉ICP备20002630号

Website construction:300.cn Changchun   management     

Jilin Province Great Great Pharmaceutical Co. LTD